Skip to main content

D. E. Shaw & Co., Inc.

Position in PRTA — Prothena Corp Public Ltd Co

CIK 1009207 New York, NY

Position in PRTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,776,164
-$1,363,568 QoQ
Shares Held
1,611,457
-8.6% QoQ
Ownership
3.14%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 187 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRTA Over Time

Shares Held

Position Value (USD)

Derivatives in PRTA

reported options exposure · as of Jun 30, 2024
CallValue
$0
CallShares
0
PutValue
$229,104
PutShares
11,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. PRTA ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRTA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,776,164 1,611,457
2026-03-31 $17,139,732 1,763,347
2025-12-31 $16,057,073 1,681,369
2025-09-30 $12,838,479 1,315,418
2025-06-30 $2,376,374 391,495
2025-03-31 $220,312 17,803
2024-06-30 $229,104 11,100
2023-03-31 $276,521 5,705
2022-12-31 $1,618,074 26,856
2022-09-30 $6,380,094 105,230
2022-06-30 $1,661,471 61,196
2022-06-30 $363,810 13,400
2022-03-31 $3,187,185 87,153
2022-03-31 $490,038 13,400
2021-12-31 $5,536,011 112,065
2021-12-31 $661,960 13,400
2021-09-30 $2,279,360 32,000
2021-09-30 $2,373,454 33,321
2021-06-30 $1,043,365 20,295
2021-03-31 $1,489,565 59,298
2020-12-31 $2,565,443 213,609
2020-09-30 $2,941,734 294,468
2020-06-30 $3,654,482 349,377
2020-03-31 $3,621,403 338,449